Published in Addiction on April 01, 1999
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health (2003) 1.43
Treating chronic hepatitis C in recovering opiate addicts: yes, we can. Dig Liver Dis (2009) 1.40
Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health (2005) 1.18
Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B. Addiction (2008) 0.91
Predictors of HAV/HBV vaccination completion among methadone maintenance clients. Res Nurs Health (2010) 0.83
Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities. BMC Public Health (2014) 0.79
The effect of vaccinated children on increased hepatitis B immunization among high-risk adults. Am J Public Health (2008) 0.75
Hepatitis infection in the treatment of opioid dependence and abuse. Subst Abuse (2008) 0.75
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev (1999) 6.93
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38
Male attractiveness and differential testosterone investment in zebra finch eggs. Science (1999) 5.14
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
A competency model for general practice: implications for selection, training, and development. Br J Gen Pract (2000) 4.25
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
ICOS is essential for effective T-helper-cell responses. Nature (2001) 4.01
Narcotic blockade. Arch Intern Med (1966) 3.80
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol (1994) 3.44
Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37
Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses. J Infect (2009) 2.24
Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev (1997) 2.20
Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem (2001) 2.16
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol (2000) 2.09
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone (1991) 2.06
Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav (2008) 2.00
A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate. Clin Allergy (1979) 1.98
Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry (1998) 1.95
A survey of the demographics of blood use. Transfus Med (2007) 1.95
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia (2007) 1.79
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78
Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord (1997) 1.76
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer (2007) 1.75
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol (1994) 1.75
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74
Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J Cell Sci (1998) 1.72
Rifampin-induced methadone withdrawal. N Engl J Med (1976) 1.70
Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
The pruritus of cholestasis. Hepatology (1999) 1.63
Expressed sequences from conidial, mycelial, and sexual stages of Neurospora crassa. Fungal Genet Biol (1997) 1.62
Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. Clin Immunol (2001) 1.59
Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophys J (1999) 1.58
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57
Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem (1999) 1.57
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57
Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques (2001) 1.57
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56
Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) (2001) 1.53
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Prevalence of sleep-disordered breathing in diastolic heart failure. Chest (1997) 1.47
In vitro studies of the effect of methadone on natural killer cell activity. Isr J Med Sci (1990) 1.46
A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol (1996) 1.45
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45
Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med (1999) 1.44
Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. Gastroenterology (1991) 1.41
An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39
Determination of sulfobromophthalein excretion in rabbits. Am J Physiol (1988) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther (1985) 1.35
Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell (1996) 1.35
STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35
Fatty acid-induced insulin resistance in adipocytes. Endocrinology (1997) 1.35
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32
Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav (2009) 1.32
Beyond informed consent: the therapeutic misconception and trust. J Med Ethics (2008) 1.32
'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res (1993) 1.32
Tumor invasion as dysregulated cell motility. Semin Cancer Biol (2001) 1.31
"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J (1992) 1.30
A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology (1992) 1.30
Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat (1990) 1.28
Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport (1994) 1.28
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol (1989) 1.27
Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27
Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol (1995) 1.26
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer (2006) 1.25
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry (2008) 1.25
A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res (1999) 1.25
Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J (1997) 1.24
Long-term methadone maintenance therapy: effects on liver function. Ann Intern Med (1972) 1.23
Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes. Clin Chim Acta (2001) 1.22
Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol (1999) 1.22
Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol (1999) 1.22
Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med (1997) 1.22
Mathematical modeling of epidermal growth factor receptor signaling through the phospholipase C pathway: mechanistic insights and predictions for molecular interventions. Biotechnol Bioeng (2000) 1.21
Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. J Virol (1982) 1.21
Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy (1997) 1.20
A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18
Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18
Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol (1996) 1.17
Medical safety and side effects of methadone in tolerant individuals. JAMA (1973) 1.17
Reactions of police officers to body-handling after a major disaster. A before-and-after comparison. Br J Psychiatry (1991) 1.17
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther (1989) 1.16
Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg (1991) 1.15
Methadone and immune function. Am J Med (1992) 1.15